Literature DB >> 17764744

Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor.

Janelle M Silvers1, Marina V Aksenova, Michael Y Aksenov, Charles F Mactutus, Rosemarie M Booze.   

Abstract

Neurotoxic viral proteins released from HIV-infected cells are believed to play a major role in the pathogenesis of the dementia displayed in a significant number of AIDS patients. HIV-1 associated neuropathology severely affects dopaminergic regions of the brain. Growing evidence indicates that HIV-1 neurotoxic proteins, such as Tat may affect the function of the dopamine transmission system. In turn, molecular components of dopamine neurotransmission may participate in a complex network of Tat-induced cell responses which result in neurodegeneration. In this study we investigated whether D1 dopamine receptors are involved in the mechanism of Tat neurotoxicity in primary rat neuronal cell cultures. We found that in rat midbrain cell cultures, which express significant levels of D1 dopamine receptors, the specific D1 antagonist SCH 23390 attenuates the cell death caused by HIV-1 Tat. In rat hippocampal cell cultures, where the expression of D1 receptors is low, SCH 23390 did not change the toxicity of Tat. Thus, the protective effect of SCH 23390 in rat primary neuronal cell cultures is a function of the level of D1 receptor protein expression. Our results provide further evidence for the involvement of the dopaminergic transmission system in the mechanism of HIV-1 Tat neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764744      PMCID: PMC2957183          DOI: 10.1016/j.neuro.2007.07.005

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  47 in total

1.  HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons.

Authors:  R Bonavia; A Bajetto; S Barbero; A Albini; D M Noonan; G Schettini
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

2.  Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum.

Authors:  M Y Aksenov; U Hasselrot; A K Bansal; G Wu; A Nath; C Anderson; C F Mactutus; R M Booze
Journal:  Neurosci Lett       Date:  2001-06-01       Impact factor: 3.046

Review 3.  Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia.

Authors:  A Nath; C Anderson; M Jones; W Maragos; R Booze; C Mactutus; J Bell; K F Hauser; M Mattson
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

Review 4.  HIV dementia: the role of the basal ganglia and dopaminergic systems.

Authors:  J R Berger; G Arendt
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

5.  Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy.

Authors:  L Del Valle; S Croul; S Morgello; S Amini; J Rappaport; K Khalili
Journal:  J Neurovirol       Date:  2000-06       Impact factor: 2.643

6.  The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.

Authors:  B M Prasad; S G Amara
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

7.  HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells.

Authors:  G Zauli; P Secchiero; L Rodella; D Gibellini; P Mirandola; M Mazzoni; D Milani; D R Dowd; S Capitani; M Vitale
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

8.  Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture.

Authors:  A Pérez; A W Probert; K K Wang; L Sharmeen
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

9.  D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons.

Authors:  Nelson Lezcano; Clare Bergson
Journal:  J Neurophysiol       Date:  2002-04       Impact factor: 2.714

10.  Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.

Authors:  Gillian Farnie; Robert B Clarke; Katherine Spence; Natasha Pinnock; Keith Brennan; Neil G Anderson; Nigel J Bundred
Journal:  J Natl Cancer Inst       Date:  2007-04-18       Impact factor: 13.506

View more
  32 in total

1.  Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.

Authors:  Landhing M Moran; Michael Y Aksenov; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

2.  Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.

Authors:  Katy M Webb; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

3.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

Review 4.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

5.  Modeling deficits in attention, inhibition, and flexibility in HAND.

Authors:  Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-25       Impact factor: 4.147

6.  Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Authors:  Katherine E Olson; Aditya N Bade; Krista L Namminga; Mary Jane Potash; R Lee Mosley; Larisa Y Poluektova; David J Volsky; Howard E Gendelman
Journal:  J Neurovirol       Date:  2018-03-28       Impact factor: 2.643

7.  Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Authors:  Christina J Schier; William D Marks; Jason J Paris; Aaron J Barbour; Virginia D McLane; William F Maragos; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurosci       Date:  2017-05-04       Impact factor: 6.167

Review 8.  Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

Authors:  Vishnudutt Purohit; Rao Rapaka; David Shurtleff
Journal:  Mol Neurobiol       Date:  2011-07-01       Impact factor: 5.590

9.  D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.

Authors:  Michael Y Aksenov; M V Aksenova; C F Mactutus; Rosemarie M Booze
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-03       Impact factor: 4.147

10.  Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors:  L M Moran; R M Booze; K M Webb; C F Mactutus
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.